EPS Diluted (Quarterly) Chart

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -0.3375
March 31, 2026 -0.3884
December 31, 2025 -0.4172
September 30, 2025 -0.4387
June 30, 2025 -0.7293
March 31, 2025 -0.7083
December 31, 2024 -0.65
September 30, 2024 -0.6191
June 30, 2024 -0.5582
March 31, 2024 -0.508
December 31, 2023 -0.47
September 30, 2023 -0.3741
June 30, 2023 -0.3698
March 31, 2023 -0.4472
December 31, 2022 -0.5329
Date Value
September 30, 2022 -0.3938
June 30, 2022 -0.4454
March 31, 2022 -0.4471
December 31, 2021 -0.49
September 30, 2021 -0.4472
June 30, 2021 -0.4504
March 31, 2021 -0.4083
December 31, 2020 -0.3869
September 30, 2020 -0.3489
June 30, 2020 -0.3392
March 31, 2020 -0.3114
December 31, 2019 -0.2248
September 30, 2019 -0.1935
December 31, 2018 -0.0793
September 30, 2018 -0.386

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Agenus, Inc. -0.0146
Amgen, Inc. 4.366
BioCryst Pharmaceuticals, Inc. 0.2957
Imunon, Inc. -0.5412
Curis, Inc. -4.017

EPS Diluted (Quarterly) Related Metrics